About
mCRPC
PLUVICTO—now available for PSMA+ mCRPC before chemotherapy
If you’ve had hormone therapy, it may be time for PLUVICTO. Learn more about eligibility by clicking the link below.
Considering your next mCRPC treatment
There is a lot to process when hearing your, or a loved one’s, prostate cancer has spread.
About mCRPC: metastatic Castration-Resistant Prostate Cancer
There are different types of prostate cancer that you may have heard of:
Prostate cancer that has spread outside the prostate is called metastatic
Prostate cancer that is no longer responding to hormone treatment that lowers testosterone is called castration-resistant
When your cancer is metastatic and castration-resistant, it is called mCRPC.
If you have mCRPC, you may also be PSMA+ (prostate-specific membrane antigen positive)
You can find out if you are PSMA+ with a PSMA-PET scan
A PSMA-PET scan is an imaging test that allows your doctor to check for PSMA+ cells, including prostate cancer cells, in your body.
PET, positron emission tomography.